Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Press/Media
Datasets
Activities
Fellowships, Honors, and Prizes
Search by expertise, name or affiliation
The efficacy, effectiveness and cost-effectiveness of inactivated influenza virus vaccines
Kristin L. Nichol
Research output
:
Contribution to journal
›
Review article
›
peer-review
232
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'The efficacy, effectiveness and cost-effectiveness of inactivated influenza virus vaccines'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Cost-effectiveness
100%
Influenza
100%
Influenza Vaccine
100%
Economic Benefits
66%
Benefits of Vaccination
66%
Older Adults
33%
Potential Gains
33%
Vaccination
33%
Health Benefits
33%
Health Economics
33%
Young children
33%
Developing Countries
33%
Economic Study
33%
Influenza Vaccination
33%
Cost Savings
33%
All Ages
33%
Global Burden
33%
Subtropical Region
33%
Medicine and Dentistry
Health Care Cost
100%
Cost-Effectiveness Analysis
100%
Influenza Vaccine
100%
High Risk Population
50%
Toddlers
50%
Influenza Vaccination
50%
Pharmacology, Toxicology and Pharmaceutical Science
Live Attenuated Influenza Vaccine
100%